After a whirlwind September that saw many of you rallying your communities, spreading the word, and making a difference, we’re welcoming autumn, fall colors, and the chance to share some great new write-ups about the projects and programs your efforts are supporting. Read on! Research Advocacy Patient Support Events Ways to Give
Audra Moran, President & CEO of OCRA, appeared on PIX11 in New York City to share updates on the fight against ovarian cancer as we kick off Ovarian Cancer Awareness Month — including the importance of knowing your genetic risk. “The important thing for people to know is your family history,” says Moran. “If you … Continued
All month long, visit any Newk’s Eatery restaurant across the country to support the fight against ovarian cancer. Newk’s Cares, the ovarian cancer awareness movement founded by fast-casual restaurant Newk’s Eatery, is committed to saving more lives while honoring the legacy of late co-founder, and former OCRA board member, Lori Newcomb (pictured, right). Newk’s Cares … Continued
All eyes are on September as we gear up for Ovarian Cancer Awareness Month and OCRA’s Uniting for Hope Ovarian Cancer National Conference. So with that in mind, we’re flipping the order of the news this month. Are you ready? Events Ways to Give Research Patient Support Advocacy
Planned giving can be an uncomfortable conversation for many; after all, it’s a conversation about what happens when we die. And talking about it within the context of our community – those touched by the deadliest gynecologic cancer – can feel awkward, if not downright off-putting. But planned giving is an important fundraising component of … Continued
We hope everyone is enjoying some sunshine while keeping cool and hydrated. OCRA is keeping busy – planning our Uniting for Hope Ovarian Cancer National Conference; offering support to patients and their loved ones; funding grantees and their quest for better treatments and a cure. Read on to see the latest. Research Advocacy Patient Support … Continued
Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The Wistar Institute and their colleagues at University of Pennsylvania and The University of Colorado Anschutz Medical Campus. An oncogene is a mutated version of a … Continued
We hope everyone is keeping cool while feeling the warmth from our ovarian cancer community. And we hope to see many of your faces online this September when we host our Ovarian Cancer National Conference! Read below to find out details, along with other important news. Research Advocacy Patient Support Events Ways to Give Did you … Continued
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients. Bioinformatics is a scientific discipline that enables researchers to collect, process and analyze a vast amount of biological and medical data via computers and statistical techniques. In the case of … Continued
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month. Below, we highlight breakthroughs in our understanding and treatment of ovarian cancer, thanks to the ongoing work of our grantees. And be sure to keep scrolling down to discover new ways to get involved and get support! Research … Continued
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of the University of California, San Diego Moores Cancer Center. High-grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, with approximately 75% of epithelial ovarian cancers … Continued
Audra Moran, President and CEO of OCRA, and Richard Pazdur, MD, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer during a recent discussion. Topics that were covered include the critical role that patients play in research, drug regulation, and the policies that affect the … Continued
Get email updates about research news, action alerts, and ways to join the fight.
